Compare $ATOS vs $KYNB | Chartloom

Compare

$ATOS vs $KYNB

Atossa Therapeutics Inc · Kyntra Bio Inc

ATOS

Atossa Therapeutics Inc

KYNB

Kyntra Bio Inc

Compare $ATOS vs $KYNB

Comparing Atossa Therapeutics Inc and Kyntra Bio Inc

ATOSAtossa Therapeutics Inc

KYNBKyntra Bio Inc

ATOSAtossa Therapeutics Inc

Market cap

$24M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.2%

52W performance

-85.3%

FCF yield

-147.1%

KYNBKyntra Bio Inc

Market cap

$25M

P/E (TTM)

0.14x

Forward P/E (NTM)

—

Forward P/S (NTM)

3.52x

Rev growth (TTM)

-91.4%

YTD performance

-33.3%

52W performance

-46.4%

FCF yield

-153.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATOS

KYNB

Detailed metrics comparison

ATOS

Atossa Therapeutics Inc

KYNB

Kyntra Bio Inc

Market Cap

ATOS$24M

KYNB$25M

Enterprise Value

ATOS$-2M

KYNB$-26M

Price

ATOS$2.44

KYNB$6.11

P/E Ratio

ATOSN/A

KYNB0.14x

P/S Ratio

ATOS145.95x

KYNB5.36x

EV/Sales

ATOS-17.14x

KYNB-5.61x

EV/EBITDA

ATOS0.00x

KYNB0.00x

P/B Ratio

ATOS0.87x

KYNB0.97x

P/FCF Ratio

ATOSN/A

KYNBN/A

EV/FCF

ATOS0.05x

KYNB0.68x

PEG Ratio

ATOSN/A

KYNBN/A

Forward P/E (NTM)

ATOSN/A

KYNBN/A

Forward P/S (NTM)

ATOSN/A

KYNB3.52x

Revenue (TTM)

ATOS$0

KYNB$5M

Revenue Growth (YoY)

ATOSN/A

KYNB-91.4%

Forward Rev Growth

ATOS184.1%

KYNB21.6%

Gross Margin (TTM)

ATOS62.5%

KYNB6.3%

Operating Margin (TTM)

ATOS0.0%

KYNB0.0%

EBITDA Margin (TTM)

ATOS0.0%

KYNB-1083.7%

Net Margin (TTM)

ATOS0.0%

KYNB3967.8%

FCF Margin (TTM)

ATOSN/A

KYNB-824.4%

Net Income (TTM)

ATOS$-38M

KYNB$183M

FCF (TTM)

ATOS$-36M

KYNB$-38M

EPS (TTM)

ATOS-$4.23

KYNB$45.25

ROE (TTM)

ATOS-10299.0%

KYNB-29091.0%

ROA (TTM)

ATOS-8578.0%

KYNB156.8%

ROIC (TTM)

ATOS-10299.0%

KYNB-25645.0%

Cash

ATOS$26M

KYNB$51M

Debt

ATOS$0

KYNB$0

Net Cash/Debt

ATOS$26M

KYNB$51M

Current Ratio (TTM)

ATOS5.69x

KYNB2.69x

Quick Ratio (TTM)

ATOS4.81x

KYNB2.57x

Debt/Equity (TTM)

ATOS0.00x

KYNB0.59x

Debt/Assets (TTM)

ATOS0.0%

KYNB0.0%

Interest Coverage (TTM)

ATOSN/A

KYNBN/A

Net Debt/EBITDA (TTM)

ATOS0.00x

KYNB0.00x

Beta

ATOS1.39

KYNB1.07

52W Performance

ATOS-85.3%

KYNB-46.4%

YTD Performance

ATOS-74.2%

KYNB-33.3%

% from 52W High

ATOS-87.4%

KYNB-47.6%

% from 52W Low

ATOS43.5%

KYNB8.7%

Asset Turnover (TTM)

ATOS0.01x

KYNB0.05x

FCF Yield (TTM)

ATOS-147.1%

KYNB-153.8%

Earnings Yield (TTM)

ATOS-155.0%

KYNB740.3%

Dividend Yield (TTM)

ATOSN/A

KYNBN/A

Rule of 40

ATOS0.0

KYNB-915.8

EV/GP/RG

ATOSN/A

KYNBN/A

Ticker research

View ATOS research View KYNB research

Metric	ATOS Atossa Therapeutics Inc	KYNB Kyntra Bio Inc
Market & Valuation
Market Cap	$24M	$25M
Enterprise Value	$-2M	$-26M
Price	$2.44	$6.11
P/E Ratio	N/A	0.14x
P/S Ratio	145.95x	5.36x
EV/Sales	-17.14x	-5.61x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	0.97x
P/FCF Ratio	N/A	N/A
EV/FCF	0.05x	0.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.52x
Revenue & Growth
Revenue (TTM)	$0	$5M
Revenue Growth (YoY)	N/A	-91.4%
Forward Rev Growth	184.1%	21.6%
Profitability
Gross Margin (TTM)	62.5%	6.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1083.7%
Net Margin (TTM)	0.0%	3967.8%
FCF Margin (TTM)	N/A	-824.4%
Net Income (TTM)	$-38M	$183M
FCF (TTM)	$-36M	$-38M
EPS (TTM)	-$4.23	$45.25
ROE (TTM)	-10299.0%	-29091.0%
ROA (TTM)	-8578.0%	156.8%
ROIC (TTM)	-10299.0%	-25645.0%
Financial Health
Cash	$26M	$51M
Debt	$0	$0
Net Cash/Debt	$26M	$51M
Current Ratio (TTM)	5.69x	2.69x
Quick Ratio (TTM)	4.81x	2.57x
Debt/Equity (TTM)	0.00x	0.59x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	1.07
52W Performance	-85.3%	-46.4%
YTD Performance	-74.2%	-33.3%
% from 52W High	-87.4%	-47.6%
% from 52W Low	43.5%	8.7%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.05x
FCF Yield (TTM)	-147.1%	-153.8%
Earnings Yield (TTM)	-155.0%	740.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-915.8
EV/GP/RG	N/A	N/A
Ticker research	View ATOS research	View KYNB research

Valuation

P/E Ratio

KYNB

0.14x

P/S Ratio

KYNB

5.36x

ATOS

145.95x

EV/FCF

ATOS

0.05x

KYNB

0.68x

Growth & revenue

Revenue Growth TTM

KYNB

-91.4%

Forward Revenue Growth

ATOS

184.1%

KYNB

21.6%

Profitability & performance

Gross Margin

ATOS

62.5%

KYNB

6.3%

ROE

ATOS

-10299.0%

KYNB

-29091.0%

FCF Yield %

ATOS

-147.1%

KYNB

-153.8%

52-Week Performance

KYNB

-46.4%

ATOS

-85.3%

Detailed metrics comparison

ATOS

Atossa Therapeutics Inc

KYNB

Kyntra Bio Inc

Market Cap

ATOS$24M

KYNB$25M

Enterprise Value

ATOS$-2M

KYNB$-26M

Price

ATOS$2.44

KYNB$6.11

P/E Ratio

ATOSN/A

KYNB0.14x

P/S Ratio

ATOS145.95x

KYNB5.36x

EV/Sales

ATOS-17.14x

KYNB-5.61x

EV/EBITDA

ATOS0.00x

KYNB0.00x

P/B Ratio

ATOS0.87x

KYNB0.97x

P/FCF Ratio

ATOSN/A

KYNBN/A

EV/FCF

ATOS0.05x

KYNB0.68x

PEG Ratio

ATOSN/A

KYNBN/A

Forward P/E (NTM)

ATOSN/A

KYNBN/A

Forward P/S (NTM)

ATOSN/A

KYNB3.52x

Revenue (TTM)

ATOS$0

KYNB$5M

Revenue Growth (YoY)

ATOSN/A

KYNB-91.4%

Forward Rev Growth

ATOS184.1%

KYNB21.6%

Gross Margin (TTM)

ATOS62.5%

KYNB6.3%

Operating Margin (TTM)

ATOS0.0%

KYNB0.0%

EBITDA Margin (TTM)

ATOS0.0%

KYNB-1083.7%

Net Margin (TTM)

ATOS0.0%

KYNB3967.8%

FCF Margin (TTM)

ATOSN/A

KYNB-824.4%

Net Income (TTM)

ATOS$-38M

KYNB$183M

FCF (TTM)

ATOS$-36M

KYNB$-38M

EPS (TTM)

ATOS-$4.23

KYNB$45.25

ROE (TTM)

ATOS-10299.0%

KYNB-29091.0%

ROA (TTM)

ATOS-8578.0%

KYNB156.8%

ROIC (TTM)

ATOS-10299.0%

KYNB-25645.0%

Cash

ATOS$26M

KYNB$51M

Debt

ATOS$0

KYNB$0

Net Cash/Debt

ATOS$26M

KYNB$51M

Current Ratio (TTM)

ATOS5.69x

KYNB2.69x

Quick Ratio (TTM)

ATOS4.81x

KYNB2.57x

Debt/Equity (TTM)

ATOS0.00x

KYNB0.59x

Debt/Assets (TTM)

ATOS0.0%

KYNB0.0%

Interest Coverage (TTM)

ATOSN/A

KYNBN/A

Net Debt/EBITDA (TTM)

ATOS0.00x

KYNB0.00x

Beta

ATOS1.39

KYNB1.07

52W Performance

ATOS-85.3%

KYNB-46.4%

YTD Performance

ATOS-74.2%

KYNB-33.3%

% from 52W High

ATOS-87.4%

KYNB-47.6%

% from 52W Low

ATOS43.5%

KYNB8.7%

Asset Turnover (TTM)

ATOS0.01x

KYNB0.05x

FCF Yield (TTM)

ATOS-147.1%

KYNB-153.8%

Earnings Yield (TTM)

ATOS-155.0%

KYNB740.3%

Dividend Yield (TTM)

ATOSN/A

KYNBN/A

Rule of 40

ATOS0.0

KYNB-915.8

EV/GP/RG

ATOSN/A

KYNBN/A

Ticker research

View ATOS research View KYNB research

Metric	ATOS Atossa Therapeutics Inc	KYNB Kyntra Bio Inc
Market & Valuation
Market Cap	$24M	$25M
Enterprise Value	$-2M	$-26M
Price	$2.44	$6.11
P/E Ratio	N/A	0.14x
P/S Ratio	145.95x	5.36x
EV/Sales	-17.14x	-5.61x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	0.97x
P/FCF Ratio	N/A	N/A
EV/FCF	0.05x	0.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.52x
Revenue & Growth
Revenue (TTM)	$0	$5M
Revenue Growth (YoY)	N/A	-91.4%
Forward Rev Growth	184.1%	21.6%
Profitability
Gross Margin (TTM)	62.5%	6.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1083.7%
Net Margin (TTM)	0.0%	3967.8%
FCF Margin (TTM)	N/A	-824.4%
Net Income (TTM)	$-38M	$183M
FCF (TTM)	$-36M	$-38M
EPS (TTM)	-$4.23	$45.25
ROE (TTM)	-10299.0%	-29091.0%
ROA (TTM)	-8578.0%	156.8%
ROIC (TTM)	-10299.0%	-25645.0%
Financial Health
Cash	$26M	$51M
Debt	$0	$0
Net Cash/Debt	$26M	$51M
Current Ratio (TTM)	5.69x	2.69x
Quick Ratio (TTM)	4.81x	2.57x
Debt/Equity (TTM)	0.00x	0.59x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	1.07
52W Performance	-85.3%	-46.4%
YTD Performance	-74.2%	-33.3%
% from 52W High	-87.4%	-47.6%
% from 52W Low	43.5%	8.7%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.05x
FCF Yield (TTM)	-147.1%	-153.8%
Earnings Yield (TTM)	-155.0%	740.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-915.8
EV/GP/RG	N/A	N/A
Ticker research	View ATOS research	View KYNB research